Wednesday, 3 August 2016

Suitors Sniff Around Biogen In Sign Of Pharma's Hunger For New Growth Sources

The pipeline for pharmaceutical companies has been depleted for years, and there's a desire in the industry for potential takeover deals. In other news, Pfizer's profits dropped by 23 percent in its latest quarter, an antidepressant drug draws fire and an executive for GlaxoSmithKline speaks with Stat about the company's new venture with Alphabet.

No comments:

Post a Comment